Recall of Afinion AS100 Analyser, CRP and CRP Control; An in vitro diagnostic medical device (IVD)

According to Department of Health, Therapeutic Goods Administration, this recall involved a device in Australia that was produced by Inverness Medical Innovations Australia Pty Ltd.

What is this?

A correction or removal action taken by a manufacturer to address a problem with a medical device. Recalls occur when a medical device is defective, when it could be a risk to health, or when it is both defective and a risk to health.

Learn more about the data here
  • Type of Event
  • Event ID
  • Event Risk Class
    Class II
  • Event Initiated Date
  • Event Country
  • Event Source
  • Event Source URL
  • Notes / Alerts
    Australian data is current through July 2018. All of the data comes from the Australian Therapeutic Goods Administration, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Australia.
  • Extra notes in the data
  • Reason
    1) axis-shield poc as, the manufacturer of afinion crp system, warns that an information code (error code) which is displayed on the analyser screen might potentially be misinterpreted as a high crp result. 2) the crp concentration in frequently opened control vials may increase due to evaporation. therefore, the stability of opened vials of afinion crp control has been reduced from 8 to 4 weeks.
  • Action
    Alere is providing work around instructions and will be implementing a software update.


  • Model / Serial
    Afinion AS100 Analyser, CRP and CRP Control; An in vitro diagnostic medical device (IVD)Afinion AS100 AnalyserREF: 1115027, 1115173, 1115174, 1115176, 1115172, 1115175, 1115507, 1115419 & 1115516Afinion CRPREF: 1115013, 1115014 & 1115377Afinion CRP ControlREF: 1114993
  • Manufacturer


  • Manufacturer Parent Company (2017)
  • Manufacturer comment
    “We are in constant communication with regulatory agencies and competent authorities worldwide which allows us to implement global recalls or in-country communication quickly and effectively,” Abbott, which now owns St. Jude Medical told ICIJ in a statement. In addition to sending global notices to physicians worldwide, we also make sure that product advisories are available online and classification of product recalls and product advisories are determined by global regulatory bodies which can impact the timing in any given country. MD companies follow varying regulations in different countries. In come countries software is not regulated so a recall in one country related to software would not be classified as a recall or field action in another. In addition, review cycles within the regulatory process can be different in each country which can impact communication and recall timing.
  • Source